Posts tagged with ‘commercialize’

  • GlycoMar secures £ 890,000 investment

    Scottish marine biotechnology company GlycoMar Ltd has secured investment of £890,000 from new and existing investors. The investment is being used to progress the company’s anti-­‐inflammatory drug development programme. GlycoMar Limited was established in February 2005 and has its premises at the European Centre for  Marine Biotechnology, near Oban, Scotland. GlycoMar, which means ‘sweet sea’, is dedicated to the discovery, development […]
    0
  • New French-Chilean Joint Unit to Study Marine Algae

    To strengthen collaboration in the fields of ecology and marine evolutionary biology, the CNRS, UPMC and two Chilean universities signed an agreement recently for the creation of an International Joint Unit (UMI). Called EBEA, ‘Evolutionary Biology and Ecology of Algae’, the new structure focuses on the ecology, evolution and genomics of marine algae. Affiliated to the CNRS Institute of Ecology […]
    0
  • Egyptian aquaculture sector plans for further growth

    Stakeholders from Egypt’s $1.5 billion aquaculture industry will come together in Cairo this week to discuss future development of the sector. Organized by WorldFish, an international research organization, the two-day Innovation Platform meeting, on 19 and 20 February is planned in collaboration with the Egyptian Ministry of Agriculture and Land Reclamation, and supported by the Swiss Agency for Development and […]
    0
  • Economic outlook in North Carolina focuses on marine biotech

    The sea is offering the Wilmington area another path to prosperity as research and the business of marine biotechnology prepare to grow here. It’s “an industry that’s waiting to happen,” said Randall Johnson, director of the N.C. Biotechnology Center’s southeastern office. And a new umbrella organization – the Marine Biotechnologies Center of Innovation – hopes to serve as a catalyst for […]
    0
  • CSA MarineBiotech Launched

    A sound strategy for marine biotechnology research, technology development and innovation and a concerted coordination of relevant national and regional programmes are urgently needed in Europe. The Coordination and Support Action ‘MarineBiotech’ is a response to this, aiming at an ERA-NET in marine biotechnology that can deliver ‘smart, sustainable and inclusive growth’, a core objective of the Europe 2020 Strategy. Bringing […]
    0
  • UK University Research Group seeks SME partners to explore the development of three specific marine bio-resources to produce high value products: anti-cancer drugs, oxygenase biocatalysts, anti-microbials

    The marine environment is a very rich source of bio-molecules with therapeutic applications. Blue biotechnology specifically seeks to harness the biodiversity of the marine environment for access to high-value and relatively low-volume biological products. Recent advances in molecular biology (including metagenomic methods) mean that there is now remarkable potential to harness genetic biodiversity from specific marine environments for bio-product preparation. […]
    0
  • Aquapharm Biodiscovery renews deal with Croda/Sederma, harnessing Aquapharm’s collection of marine micro-organisms for cosmetics

    Leading Scottish marine biotechnology company, Aquapharm Biodiscovery Ltd, has reached a crucial new stage in the development of next generation cosmetics harnessing its unique collection of marine micro-organisms. Aquapharm, which signed a three year R&D agreement with Croda, a global leader in speciality chemicals for the personal care market in 2008, has struck a renewed deal to work with Croda’s […]
    0
  • Revenues/Profits up for Cyanotech vs. year ago

    Cyanotech Corporation, a NASDAQ-traded leader in microalgae-based, high-value nutrition and health products, headquartered in Kona, Hawaii, has announced financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011. For the fourth quarter of fiscal 2011, revenues were $5,218,000 compared to $3,814,000 for the fourth quarter of fiscal 2010. Gross profit was $1,798,000, with gross profit margin […]
    0
  • Enzymicals AG and the Institute of Marine Biotechnology e.V. establish cooperation

    Enzymicals AG, an emerging company in the field of industrial (white) biotechnology, and the Institute of Marine Biotechnology e.V. (IMaB), an association in the area of marine (blue) biotechnology, have signed a comprehensive agreement to cooperate in the future. The two institutions, both located in Greifswald, Germany, combine their competencies in the commercialization of alternative expression systems and functional genome […]
    0
  • New Astec Centre in UK to offer new opportunities for fledgling marine businesses

    The recent opening of the Astec Centre  is expected to offer a number of opportunities for fledgling  marine businesses. Astec Aquaculture Business & Science Centre is a purpose-built resource that has been created to support the growth of the aquaculture sector.  It opened its doors to businesses and researchers recently, showcasing the extensive facilities and support services that it offers. Due […]
    0